Healthy Skepticism Library item: 9684

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Wilce H.
Temazepam capsules: What was the problem?
Australian Prescriber 2004; 27:(3):58-59

Abstract:

Over the last few years, injecting drug users in Australia increasingly injected the contents of temazepam gelcaps, an activity associated with significant harm. Although changes to the Pharmaceutical Benefits Scheme in May 2002 reduced the prescription of gelcaps, they did not eliminate misuse. Temazepam capsules were withdrawn from the Australian market in March 2004. Already front-line services are reporting a decrease in harm and misuse.